FDA — authorised 17 July 1998
- Marketing authorisation holder: FOREST LABS
- Status: approved
🇺🇸 Celexa in United States
FDA authorised Celexa on 17 July 1998
Marketing authorisations
FDA — authorised 17 July 1998
- Application: NDA020822
- Marketing authorisation holder: ABBVIE
- Local brand name: CELEXA
- Indication: TABLET — ORAL
- Status: approved
FDA — authorised 22 December 1999
- Application: NDA021046
- Marketing authorisation holder: FOREST LABS
- Local brand name: CELEXA
- Indication: SOLUTION — ORAL
- Status: approved
Celexa in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Celexa approved in United States?
Yes. FDA authorised it on 17 July 1998; FDA authorised it on 17 July 1998; FDA authorised it on 22 December 1999.
Who is the marketing authorisation holder for Celexa in United States?
FOREST LABS holds the US marketing authorisation.